
Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings
Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer) | 2026-04-30 | English | |
| 424B4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer) | 2026-04-27 | English | |
| S-1 - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer) | 2026-04-17 | English | |
| 8-K - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer) | 2026-04-09 | English | |
| 10-Q Filing | 2026-02-10 | English | |
| 3 Filing | 2026-02-09 | English |
Browse filings by year
21 years- 2026 15 filings
- 2025 33 filings
- 2024 33 filings
- 2023 40 filings
- 2022 29 filings
- 2021 26 filings
- 2020 34 filings
- 2019 31 filings
- 2018 53 filings
- 2017 64 filings
- 2016 53 filings
- 2015 64 filings
- 2014 50 filings
- 2013 54 filings
- 2012 44 filings
- 2011 60 filings
- 2010 40 filings
- 2009 85 filings
- 2008 44 filings
- 2007 67 filings
- 2006 32 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39225301 | 8-K - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer) | 2026-04-30 | English | ||
| 37387950 | 424B4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer) | 2026-04-27 | English | ||
| 34662863 | S-1 - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer) | 2026-04-17 | English | ||
| 33909505 | 8-K - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer) | 2026-04-09 | English | ||
| 29121713 | 10-Q Filing | 2026-02-10 | English | ||
| 29121426 | 3 Filing | 2026-02-09 | English | ||
| 29121523 | 8-K Filing | 2026-01-28 | English | ||
| 29121760 | 8-K Filing | 2026-01-12 | English | ||
| 11994851 | Director's Dealing 2026 | 2026-01-02 | English | ||
| 11994852 | Director's Dealing 2026 | 2026-01-02 | English | ||
| 11994853 | Director's Dealing 2026 | 2026-01-02 | English | ||
| 11994855 | Director's Dealing 2026 | 2026-01-02 | English | ||
| 11994857 | Director's Dealing 2026 | 2026-01-02 | English | ||
| 11994858 | Director's Dealing 2026 | 2026-01-02 | English | ||
| 11994866 | CURRENT REPORT | 2026-01-02 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Sonoma Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35312/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35312 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35312 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35312 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35312}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sonoma Pharmaceuticals, Inc. (id: 35312)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.